Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells.

Rossi V, Di Zazzo E, Galasso G, De Rosa C, Abbondanza C, Sinisi AA, Altucci L, Migliaccio A, Castoria G.

Front Pharmacol. 2019 Feb 15;10:28. doi: 10.3389/fphar.2019.00028. eCollection 2019.

2.

PR/SET Domain Family and Cancer: Novel Insights from the Cancer Genome Atlas.

Sorrentino A, Federico A, Rienzo M, Gazzerro P, Bifulco M, Ciccodicola A, Casamassimi A, Abbondanza C.

Int J Mol Sci. 2018 Oct 19;19(10). pii: E3250. doi: 10.3390/ijms19103250.

3.

Human PRDM2: Structure, function and pathophysiology.

Sorrentino A, Rienzo M, Ciccodicola A, Casamassimi A, Abbondanza C.

Biochim Biophys Acta Gene Regul Mech. 2018 Jun 6. pii: S1874-9399(18)30071-3. doi: 10.1016/j.bbagrm.2018.06.002. [Epub ahead of print] Review.

PMID:
29883756
4.

Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex.

Federico A, Rienzo M, Abbondanza C, Costa V, Ciccodicola A, Casamassimi A.

Int J Mol Sci. 2017 Apr 29;18(5). pii: E936. doi: 10.3390/ijms18050936.

5.

c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.

Nebbioso A, Carafa V, Conte M, Tambaro FP, Abbondanza C, Martens J, Nees M, Benedetti R, Pallavicini I, Minucci S, Garcia-Manero G, Iovino F, Lania G, Ingenito C, Belsito Petrizzi V, Stunnenberg HG, Altucci L.

Clin Cancer Res. 2017 May 15;23(10):2542-2555. doi: 10.1158/1078-0432.CCR-15-2388. Epub 2016 Jun 29.

6.

Rosacea and abatacept: the first report of a possible correlation.

Lo Schiavo A, Tirri R, Peccerillo F, Abbondanza C, Russo B, Caccavale S.

G Ital Dermatol Venereol. 2016 Feb;151(1):123. No abstract available.

PMID:
26924033
7.

Prostate cancer stem cells: the role of androgen and estrogen receptors.

Di Zazzo E, Galasso G, Giovannelli P, Di Donato M, Di Santi A, Cernera G, Rossi V, Abbondanza C, Moncharmont B, Sinisi AA, Castoria G, Migliaccio A.

Oncotarget. 2016 Jan 5;7(1):193-208. doi: 10.18632/oncotarget.6220. Review.

8.

Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism.

Federico A, Aitella E, Sgambato D, Savoia A, De Bartolomeis F, Dallio M, Ruocco E, Pezone L, Abbondanza C, Loguercio C, Astarita C.

Ann Hepatol. 2015 May-Jun;14(3):420-4.

9.

HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.

Conte M, Dell'Aversana C, Benedetti R, Petraglia F, Carissimo A, Petrizzi VB, D'Arco AM, Abbondanza C, Nebbioso A, Altucci L.

Oncotarget. 2015 Jan 20;6(2):886-901.

10.

Mouse monoclonal antibodies against estrogen receptor.

De Rosa C, Rossi V, Abbondanza C.

Methods Mol Biol. 2014;1204:165-85. doi: 10.1007/978-1-4939-1346-6_15.

PMID:
25182770
11.

Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration.

Grandone A, Miraglia del Giudice E, Cirillo G, Abbondanza C, Cioffi M, Romano T, Micillo F, Marzuillo P, Perrone L.

Horm Res Paediatr. 2014;81(1):67-72. doi: 10.1159/000355017. Epub 2013 Dec 12.

PMID:
24356109
12.

Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA.

Ombra MN, Di Santi A, Abbondanza C, Migliaccio A, Avvedimento EV, Perillo B.

Biochim Biophys Acta. 2013 May;1829(5):480-6. doi: 10.1016/j.bbagrm.2013.03.003. Epub 2013 Mar 16.

PMID:
23507259
13.

PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation.

Di Zazzo E, De Rosa C, Abbondanza C, Moncharmont B.

Biology (Basel). 2013 Jan 14;2(1):107-41. doi: 10.3390/biology2010107.

14.

Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.

Castoria G, Giovannelli P, Lombardi M, De Rosa C, Giraldi T, de Falco A, Barone MV, Abbondanza C, Migliaccio A, Auricchio F.

Oncogene. 2012 Nov 15;31(46):4868-77. doi: 10.1038/onc.2011.642. Epub 2012 Jan 23.

PMID:
22266855
15.

Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework.

Napoli C, Casamassimi A, Crudele V, Infante T, Abbondanza C.

Future Cardiol. 2011 Jul;7(4):485-97. doi: 10.2217/fca.11.24. Review.

PMID:
21797745
16.

Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma.

Nersita R, Matrone A, Klain M, Scavuzzo F, Vitolo G, Abbondanza C, Carlino MV, Giacco V, Amato G, Carella C.

Clin Endocrinol (Oxf). 2012 Jan;76(1):142-6. doi: 10.1111/j.1365-2265.2011.04183.x.

PMID:
21781145
17.

Highlighting chromosome loops in DNA-picked chromatin (DPC).

Abbondanza C, De Rosa C, Ombra MN, Aceto F, Medici N, Altucci L, Moncharmont B, Puca GA, Porcellini A, Avvedimento EV, Perillo B.

Epigenetics. 2011 Aug;6(8):979-86. doi: 10.4161/epi.6.8.16060. Epub 2011 Aug 1.

PMID:
21725198
18.

Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines.

Abbondanza C, De Rosa C, D'Arcangelo A, Pacifico M, Spizuoco C, Piluso G, Di Zazzo E, Gazzerro P, Medici N, Moncharmont B, Puca GA.

J Cell Physiol. 2012 Mar;227(3):964-75. doi: 10.1002/jcp.22803.

PMID:
21503890
19.

Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.

Rossi V, Bellastella G, De Rosa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA.

J Cell Physiol. 2011 May;226(5):1334-9. doi: 10.1002/jcp.22461.

PMID:
20945400
20.

Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues.

Rossiello L, D'Andrea F, Grella R, Signoriello G, Abbondanza C, De Rosa C, Prudente M, Morlando M, Rossiello R.

Wound Repair Regen. 2009 Sep-Oct;17(5):750-7. doi: 10.1111/j.1524-475X.2009.00530.x.

PMID:
19769727
21.

Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2.

Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M, Bellastella G, Visconti D, De Bellis A, Moncharmont B, De Rosa G, Puca GA, Bellastella A, Sinisi AA.

J Cell Physiol. 2009 Dec;221(3):771-7. doi: 10.1002/jcp.21920.

PMID:
19746436
22.

Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells.

Salvatore P, Casamassimi A, Sommese L, Fiorito C, Ciccodicola A, Rossiello R, Avallone B, Grimaldi V, Costa V, Rienzo M, Colicchio R, Williams-Ignarro S, Pagliarulo C, Prudente ME, Abbondanza C, Lamberti F, Baroni A, Buommino E, Farzati B, Tufano MA, Ignarro LJ, Napoli C.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9427-32. doi: 10.1073/pnas.0803602105. Epub 2008 Jun 30.

23.

Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma.

Abbondanza C, de Nigris F, De Rosa C, Rossiello R, Puca GA, Napoli C.

Oncol Res. 2008;17(1):33-41.

PMID:
18488713
24.

Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia.

Napoli C, William-Ignarro S, Byrns R, Balestrieri ML, Crimi E, Farzati B, Mancini FP, de Nigris F, Matarazzo A, D'Amora M, Abbondanza C, Fiorito C, Giovane A, Florio A, Varricchio E, Palagiano A, Minucci PB, Tecce MF, Giordano A, Pavan A, Ignarro LJ.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):571-9. doi: 10.1038/ncpcardio1214. Epub 2008 Apr 15.

PMID:
18414452
25.

DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression.

Perillo B, Ombra MN, Bertoni A, Cuozzo C, Sacchetti S, Sasso A, Chiariotti L, Malorni A, Abbondanza C, Avvedimento EV.

Science. 2008 Jan 11;319(5860):202-6. doi: 10.1126/science.1147674.

26.

Proteomic analysis of MCF-7 cell lines expressing the zinc-finger or the proline-rich domain of retinoblastoma-interacting-zinc-finger protein.

Chambery A, Farina A, Di Maro A, Rossi M, Abbondanza C, Moncharmont B, Malorni L, Cacace G, Pocsfalvi G, Malorni A, Parente A.

J Proteome Res. 2006 May;5(5):1176-85.

PMID:
16674107
27.

Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation.

Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B, Puca GA.

Exp Cell Res. 2006 Feb 1;312(3):340-9. Epub 2005 Dec 13.

PMID:
16356493
28.

The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation.

Rossi M, Abbondanza C, D'Arcangelo A, Gazzerro P, Medici N, Moncharmont B, Puca GA.

Cancer Lett. 2004 Nov 25;215(2):229-37.

PMID:
15488642
29.

17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells.

Chieffi P, Kisslinger A, Sinisi AA, Abbondanza C, Tramontano D.

Int J Oncol. 2003 Sep;23(3):797-801.

PMID:
12888920
30.

Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies.

Schroeijers AB, Scheffer GL, Reurs AW, Pijnenborg AC, Abbondanza C, Wiemer EA, Scheper RJ.

J Histochem Cytochem. 2001 Nov;49(11):1379-85.

PMID:
11668191
31.

Differentiation of myeloid cell lines correlates with a selective expression of RIZ protein.

Gazzerro P, Bontempo P, Schiavone EM, Abbondanza C, Moncharmont B, Armetta I, Medici N, De Simone M, Nola E, Puca GA, Molinari AM.

Mol Med. 2001 Aug;7(8):552-60.

32.

Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues.

Pasquali D, Rossi V, Esposito D, Abbondanza C, Puca GA, Bellastella A, Sinisi AA.

J Clin Endocrinol Metab. 2001 May;86(5):2051-5.

PMID:
11344205
33.

Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation.

Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F.

EMBO J. 2000 Oct 16;19(20):5406-17.

34.

Estradiol induces functional inactivation of p53 by intracellular redistribution.

Molinari AM, Bontempo P, Schiavone EM, Tortora V, Verdicchio MA, Napolitano M, Nola E, Moncharmont B, Medici N, Nigro V, Armetta I, Abbondanza C, Puca GA.

Cancer Res. 2000 May 15;60(10):2594-7.

35.

Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells.

Piluso G, Mirabella M, Ricci E, Belsito A, Abbondanza C, Servidei S, Puca AA, Tonali P, Puca GA, Nigro V.

J Biol Chem. 2000 May 26;275(21):15851-60.

36.

Regulation of p53 function in normal and malignant cells.

Tortora V, Bontempo P, Verdicchio M, Armetta I, Abbondanza C, Schiavone EM, Nola E, Puca GA, Molinari AM.

Adv Exp Med Biol. 1999;472:89-100. Review. No abstract available.

PMID:
10736619
37.
38.

The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action.

Abbondanza C, Medici N, Nigro V, Rossi V, Gallo L, Piluso G, Belsito A, Roscigno A, Bontempo P, Puca AA, Molinari AM, Moncharmont B, Puca GA.

Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3130-5.

39.

Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein).

Medici N, Abbondanza C, Nigro V, Rossi V, Piluso G, Belsito A, Gallo L, Roscigno A, Bontempo P, Puca AA, Molinari AM, Moncharmont B, Puca GA.

Biochem Biophys Res Commun. 1999 Nov 2;264(3):983-9.

PMID:
10544042
40.

Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell.

Abbondanza C, Rossi V, Roscigno A, Gallo L, Belsito A, Piluso G, Medici N, Nigro V, Molinari AM, Moncharmont B, Puca GA.

J Cell Biol. 1998 Jun 15;141(6):1301-10.

41.

Identification of the Syrian hamster cardiomyopathy gene.

Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, Nigro G, Ventura C, Abbondanza C, Molinari AM, Acampora D, Nishimura M, Hayashizaki Y, Puca GA.

Hum Mol Genet. 1997 Apr;6(4):601-7.

PMID:
9097966
42.

Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein.

Nigro V, Piluso G, Belsito A, Politano L, Puca AA, Papparella S, Rossi E, Viglietto G, Esposito MG, Abbondanza C, Medici N, Molinari AM, Nigro G, Puca GA.

Hum Mol Genet. 1996 Aug;5(8):1179-86.

PMID:
8842738
43.

A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers.

Castoria G, Migliaccio A, Bilancio A, Pagano M, Abbondanza C, Auricchio F.

Int J Cancer. 1996 Mar 1;65(5):574-83.

44.

Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription.

Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M.

Science. 1994 Jun 3;264(5164):1455-8.

PMID:
8197458
45.

A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis.

Nigro V, Napolitano M, Abbondanza C, Medici N, Puca AA, Schiavulli M, Armetta I, Moncharmont B, Puca GA, Molinari AM.

Cancer Lett. 1994 Apr 29;79(1):73-5.

PMID:
8187056
46.

Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor.

Abbondanza C, de Falco A, Nigro V, Medici N, Armetta I, Molinari AM, Moncharmont B, Puca GA.

Steroids. 1993 Jan;58(1):4-12.

PMID:
7679226
47.

Purified estrogen receptor enhances in vitro transcription.

Nigro V, Molinari AM, Armetta I, de Falco A, Abbondanza C, Medici N, Puca GA.

Biochem Biophys Res Commun. 1992 Jul 31;186(2):803-10.

PMID:
1497666
48.

[Optic microscope study of degree of adaptability of glass-ionomer cement].

Carnovale F, Abbondanza C.

Prog Odontoiatr. 1991 Jun;4(7):40-6. Italian. No abstract available.

PMID:
1884049
49.

Proteolytic activity of the purified hormone-binding subunit in the estrogen receptor.

Molinari AM, Abbondanza C, Armetta I, Medici N, Minucci S, Moncharmont B, Nigro V, Puca GA.

Proc Natl Acad Sci U S A. 1991 May 15;88(10):4463-7.

50.

Supplemental Content

Loading ...
Support Center